Novo Nordisk appoints new head of drug discovery

Novo Nordisk has appointed the individual who will be leading the company's Global Drug Discovery going forward. The firm chose an internal candidate.

Photo: Stine Tidsvilde

Novo Nordisk has named the person who will henceforth lead the pharmaceutical firm's unit for Global Drug Discovery, where new drugs are developed in early stages.

As Marcus Schindler takes over the role of chief scientific officer and executive vice president of research and early development after Mads Krogsgaard's Thomsen, this position has become vacant.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs